When will Loblaw report earnings and how will that affect L.TO stock?

Loblaw reports on 25 Feb 2026 at 13:30 EST. Expect L.TO stock volatility as investors digest same-store sales, pharmacy margins, and capital spending guidance. Positive surprises typically lift the TSX stock, while weak margin commentary can trigger pullbacks.

What is Meyka AI’s short-term price view for L.TO stock?

Meyka AI’s short-term monthly forecast is **C$67.44** and the quarterly projection is **C$43.62**. These are model outputs based on current data and not guarantees. Traders should combine this with real-time earnings results and guidance.

How does Loblaw’s valuation compare within its sector for L.TO stock?

Loblaw’s market PE is **32.94** and the consumer defensive sector average PE is near **30.59**. Loblaw trades with a premium tied to scale and cash flow, but investors should weigh this against its **1.75** debt-to-equity ratio and interest coverage.

What are the main risks investors should watch for in L.TO stock?

Key risks include margin compression from discount banners, execution costs for the **C$2.4 billion** expansion, and sensitivity to higher interest costs. Monitoring guidance and cash flow statements after the report will be critical for L.TO stock holders.

CA Stocks

Pre-Market 25 Feb 2026: L.TO Loblaw (TSX) earnings spotlight: key numbers ahead

ByHuzaifa Zahoor February 25, 2026February 25, 2026

L.TO stock opens pre-market at C$67.52 as Loblaw Companies Limited prepares to report earnings on 25 Feb 2026. Price is down -2.51% from the prior close, with volume running at 2,172,247 shares. Investors will watch same-store sales, pharmacy margins, and PC Optimum engagement. Management guidance and capital spend plans — including a C$2.4 billion 2026 investment — are likely to move the stock in the TSX pre-market session.